Literature DB >> 12497294

[Paraneoplastic cerebellar degeneration as initial presentation of a pancreatic small-cell carcinoma].

P Salmerón-Ato1, V Medrano, A Morales-Ortiz, F A Martínez-García, R Villaverde-González, A Bas, A Fernández-Barreiro, J M Moltó-Jordà.   

Abstract

INTRODUCTION: Oat (small) cell carcinoma is the type of tumour most frequently associated to neurologic paraneoplastic syndromes. It is usually located in the lungs although it has been described in some other locations. Cerebellar symptoms may appear alone, associated to anti Yo antibodies ( Breast and gynaecologic carcinomas), or as manifestation of a more generalized paraneoplastic encephalopathy, associated to signs and symptoms of some other neurologic systems affected. CASE REPORT: A 52 year old patient consulted due to a pancerebellar clinical picture, which started about two months before, and later associated to polineuropathy. Abdominal CT showed a 4 cm mass in the head of the pancreas. Pathologic evaluation demonstrated a poorly differentiated small cell pancreatic tumour. Anti Hu antibodies in high titres were found both in serum and cerebrospinal fluid. DISCUSSION: The association of anti Hu immunity and paraneoplastic encephalomyelitis has been observed in patients with neuroblastoma, seminomas, colorectal, breast and prostate carcinomas and some types of sarcoma. Only about 1% of pancreatic malignancies correspond to small cell type. We have not found any previous report about the association between a paraneoplastic syndrome and pancreatic poorly differentiated small cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12497294

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  1 in total

1.  Paraneoplastic Cerebellar Degeneration as Initial Presentation of Papillary Carcinoma of the Fallopian Tube: Evaluation and Usefulness of (18)F-FDG PET-CT. Case Report and Literature Review.

Authors:  Nayelli Ortega López; Digna Pachuca González; José Alfonso Rumoroso García; Juan Carlos García Reyna; Luis Felipe Alva López
Journal:  Nucl Med Mol Imaging       Date:  2012-10-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.